Suchergebnisse - "Gander, Hubert"

PubPharm (61)

1

Crosstalk between purinergic receptor P2Y11 and chemokine receptor CXCR7 is regulated by CXCR4 in human macrophages

enthalten in: Cellular and molecular life sciences : CMLS | 2024

von Klaver, D. | Gander, H. | Frena, B. | +2

2

Crosstalk between purinergic receptor $ P2Y_{11} $ and chemokine receptor CXCR7 is regulated by CXCR4 in human macrophages

enthalten in: Cellular and molecular life sciences | 2024

von Klaver, D. | Gander, H. | Frena, B. | +2

3

The P2Y11 receptor of human M2 macrophages activates canonical and IL-1 receptor signaling to translate the extracellular danger signal ATP into anti-inflammatory and pro-angiogenic responses

enthalten in: Cellular and molecular life sciences : CMLS | 2022

von Klaver, D. | Gander, H. | Dobler, G. | +2

4

The $ P2Y_{11} $ receptor of human M2 macrophages activates canonical and IL-1 receptor signaling to translate the extracellular danger signal ATP into anti-inflammatory and pro-angiogenic responses

enthalten in: Cellular and molecular life sciences | 2022

von Klaver, D. | Gander, H. | Dobler, G. | +2

5

The $ P2Y_{11} $ receptor of human M2 macrophages activates canonical and IL-1 receptor signaling to translate the extracellular danger signal ATP into anti-inflammatory and pro-angiogenic responses

enthalten in: Cellular and molecular life sciences | 2022

von Klaver, D. | Gander, H. | Dobler, G. | +2

6

The human G protein-coupled ATP receptor P2Y11 is a target for anti-inflammatory strategies

enthalten in: British journal of pharmacology | 2021

von Gruenbacher, G. | Gander, H. | Dobler, G. | +3

7

The human G protein‐coupled ATP receptor P2Y11 is a target for anti‐inflammatory strategies

enthalten in: British Journal of Pharmacology | 2021

von Gruenbacher, G. | Gander, H. | Dobler, G. | +3

8

The Human G Protein-Coupled ATP Receptor P2Y11 Is Associated With IL-10 Driven Macrophage Differentiation

enthalten in: Frontiers in immunology | 2019

von Gruenbacher, G. | Gander, H. | Rahm, A. | +5

9

Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2017

von Pichler, R. | Gruenbacher, G. | Culig, Z. | +6

10

Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer

enthalten in: Cancer immunology immunotherapy | 2016

von Pichler, R. | Gruenbacher, G. | Culig, Z. | +6

1
2
3
4
5
6
7
Nächster »
[7]